Your browser doesn't support javascript.
loading
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis.
Oba, Ken; Adachi, Maki; Kobayashi, Tomoya; Takaya, Eichi; Shimokawa, Daiki; Fukuda, Toshinori; Takahashi, Kengo; Yagishita, Kazuyo; Ueda, Takuya; Tsunoda, Hiroko.
Afiliación
  • Oba K; Department of Radiology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
  • Adachi M; Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.
  • Kobayashi T; Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.
  • Takaya E; AI Lab, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Shimokawa D; Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.
  • Fukuda T; Department of Radiology, Oregon Health of Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239-2098, USA.
  • Takahashi K; Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.
  • Yagishita K; Department of Radiology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
  • Ueda T; Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan. takuya.ueda.d3@tohoku.ac.jp.
  • Tsunoda H; AI Lab, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan. takuya.ueda.d3@tohoku.ac.jp.
Breast Cancer ; 2024 Mar 07.
Article en En | MEDLINE | ID: mdl-38448777
ABSTRACT

BACKGROUND:

Developing a deep learning (DL) model for digital breast tomosynthesis (DBT) images to predict Ki-67 expression.

METHODS:

The institutional review board approved this retrospective study and waived the requirement for informed consent from the patients. Initially, 499 patients (mean age 50.5 years, range 29-90 years) referred to our hospital for breast cancer were participated, 126 patients with pathologically confirmed breast cancer were selected and their Ki-67 expression measured. The Xception architecture was used in the DL model to predict Ki-67 expression levels. The high Ki-67 vs low Ki-67 expression diagnostic performance of our DL model was assessed by accuracy, sensitivity, specificity, areas under the receiver operating characteristic curve (AUC), and by using sub-datasets divided by the radiological characteristics of breast cancer.

RESULTS:

The average accuracy, sensitivity, specificity, and AUC were 0.912, 0.629, 0.985, and 0.883, respectively. The AUC of the four subgroups separated by radiological findings for the mass, calcification, distortion, and focal asymmetric density sub-datasets were 0.890, 0.750, 0.870, and 0.660, respectively.

CONCLUSIONS:

Our results suggest the potential application of our DL model to predict the expression of Ki-67 using DBT, which may be useful for preoperatively determining the treatment strategy for breast cancer.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Japón